RCC2 play an oncogenic role by promoting proliferation and migration of DDP-resistant ovarian cancer cell lines and inhibiting cell apoptosis by regulating RalA signaling pathway (Gong et al., 2019). This evidence concerns the gene RCC2 and ovarian carcinoma.